Tzu-lan Yeh

Mansfield Road
Oxford, ENG OX13TA, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Author Correction: Normal tissue radioprotection by amifostine via Warburg-type effects.

Author Correction: Normal tissue radioprotection by amifostine via Warburg-type effects.

Journal: Scientific reports

Published: February 03, 2025

Structure-Activity Relationship and Crystallographic Studies on 4-Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors.

Structure-Activity Relationship and Crystallographic Studies on 4-Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors.

Journal: ChemMedChem

Published: September 30, 2019

The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases.

The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases.

Journal: ACS chemical biology

Published: July 10, 2019

Small-molecules that covalently react with a human prolyl hydroxylase - towards activity modulation and substrate capture.

Small-molecules that covalently react with a human prolyl hydroxylase - towards activity modulation and substrate capture.

Journal: Chemical communications (Cambridge, England)

Published: November 20, 2018

Selective Inhibitors of a Human Prolyl Hydroxylase (OGFOD1) Involved in Ribosomal Decoding.

Selective Inhibitors of a Human Prolyl Hydroxylase (OGFOD1) Involved in Ribosomal Decoding.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: September 19, 2018

A Fluorescent Benzo[g]isoquinoline-Based HIF Prolyl Hydroxylase Inhibitor for Cellular Imaging.

A Fluorescent Benzo[g]isoquinoline-Based HIF Prolyl Hydroxylase Inhibitor for Cellular Imaging.

Journal: ChemMedChem

Published: July 21, 2018

Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials.

Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials.

Journal: Chemical science

Published: May 10, 2017

Normal tissue radioprotection by amifostine via Warburg-type effects.

Normal tissue radioprotection by amifostine via Warburg-type effects.

Journal: Scientific reports

Published: April 12, 2016

Therapeutic targeting of oxygen-sensing prolyl hydroxylases abrogates ATF4-dependent neuronal death and improves outcomes after brain hemorrhage in several rodent models.

Therapeutic targeting of oxygen-sensing prolyl hydroxylases abrogates ATF4-dependent neuronal death and improves outcomes after brain hemorrhage in several rodent models.

Journal: Science translational medicine

Published: March 04, 2016

A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1.

A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1.

Journal: ChemMedChem

Published: October 29, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026